Noram Ventures Intends to Diversify into the Regulated Marijuana Industry

Life Science Investing News

Noram Ventures Inc. (TSXV:NRM) has initiated discussions with parties in Canada and the United States that have applied for commercial licenses to legally produce marijuana. In Canada, the parties have applied to Health Canada to become licensed producers, and would be authorized to posess and sell marijuana for medical purposes.

 Noram Ventures Inc. (TSXV:NRM) has initiated discussions with parties in Canada and the United States that have applied for commercial licenses to legally produce marijuana. In Canada, the parties have applied to Health Canada to become licensed producers, and would be authorized to posess and sell marijuana for medical purposes.

As quoted in the press release:

In Canada, the Company is in discussions with parties that have applied to Health Canada to become licensed producers under the new Marihuana for Medical Purposes Regulations (MMPR) that went into effect April 1, 2014. Under the MMPR, licensed producers can be authorized to possess, sell and or provide, ship, deliver, transport, destroy, produce, export and or import marihuana for medical purposes.

In the United States, the Company is in discussion with parties who have applied to the Washington State Liquor Control Board to become licensed to produce, process and sell recreational marihuana. While medical marihuana is legal in 20 US states, Washington along with Colorado are the only states to legalize the non medical use of marihuana.

Click here to read the Noram Ventures Inc. (TSXV:NRM) press release
Click here to see the Noram Ventures Inc. (TSXV:NRM) profile.

The Conversation (0)
×